Antriabio, Inc.
Get Full AccessDescription
- AntriaBio is a biopharmaceutical company with a platform to develop novel extended release therapies. Our platform combines proprietary formulation and manufacturing capabilities with well-known molecules to significantly improve standards of care. AntriaBio's lead product candidate is AB101, an injectable once-weekly basal insulin for type 1 and type 2 diabetes that addresses a $11 billion market where the current standard of care is a once-daily basal insulin injection. We believe that our development strategy increases the probability of technical success while reducing safety and efficacy concerns, approval risks, and overall development costs. We also believe that our approach will result in significantly improved and more efficacious therapies with substantial benefits to the global diabetic population.For more information visit: www.antriabio.com.
-
Headquarters:1450 Infinite Drive , Louisville, Colorado, United States
More -
Phone Number: +1 303-222-2128
-
Website: https://www.antriabio.com
-
Employees:10
-
Revenue:$10 - 50M
-
Legal Name:Antriabio, Inc.
-
Antriabio, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541714 |
Show More
Frequently Asked Questions regarding Antriabio, Inc.
-
Where are Antriabio, Inc.'s Headquarters?
Antriabio, Inc.'s Headquarters are in 1450 Infinite Drive ,Louisville,Colorado,United States
-
What is Antriabio, Inc.'s phone number?
Antriabio, Inc.'s phone number is +1 303-222-2128
-
What is Antriabio, Inc.'s official website?
Antriabio, Inc.'s official website is https://www.antriabio.com
-
What is Antriabio, Inc.'s Revenue?
Antriabio, Inc.'s revenue is $10 - 50M
-
What is Antriabio, Inc.'s NAICS code?
Antriabio, Inc.'s NAICS code is 541714
-
How many employees are working in Antriabio, Inc.
Antriabio, Inc. has 10 employees
-
What is Antriabio, Inc.'s Industry?
Antriabio, Inc. is in the industry of Biotechnology